{
  "id": "clinical#screening_cues_072b8ff0",
  "content": "C. The symptoms are not attributable to another medical condition\n(e.g., anatomical lesions and infections of the brain, visual epi-\nlepsies) and are not better explained by another mental disorder\n(e.g., delirium, major neurocognitive disorder, schizophrenia) or\nhypnopompic hallucinations.\nOther Phencyclidine-Induced Disorders 251\nOther Phencyclidine-Induced\nDisorders\nOther phencyclidine-induced disorders are described in other chap-\nters of the book with disorders with which they share phenomenol-\nogy (see the substance/medication-induced mental disorders in these\nchapters): phencyclidine-induced psychotic disorder (“Schizophre-\nnia Spectrum and Other Psychotic Disorders”); phencyclidine-\ninduced bipolar disorder (“Bipolar and Related Disorders”); phency-\nclidine-induced depressive disorder (“Depressive Disorders”); and\nphencyclidine-induced anxiety disorder (“Anxiety Disorders”). For\nphencyclidine-induced intoxication delirium, see the criteria and dis-\ncussion of delirium in the chapter “Neurocognitive Disorders.” These\nphencyclidine-induced disorders are diagnosed instead of phencycli-\ndine intoxication only when the symptoms are sufficiently severe to\nwarrant independent clinical attention.\nOther Hallucinogen-Induced\nDisorders\nThe following other hallucinogen-induced disorders are described in\nother chapters of the book with disorders with which they share phe-\nnomenology (see the substance/medication-induced mental disor-\nders in these chapters): other hallucinogen-induced psychotic\ndisorder (“Schizophrenia Spectrum and Other Psychotic Disorders”);\nother hallucinogen-induced bipolar disorder (“Bipolar and Related\nDisorders”); other hallucinogen-induced depressive disorder (“De-",
  "metadata": {
    "source": "DSM-5",
    "url": "https://psychiatry.org/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues C. The symptoms are not attributable to another medical condition\n(e.g., anatomical lesions and infections of the brain, visual epi-\nlepsies) and are not better explained by another mental disorder\n(e.g., delirium, major neurocognitive disorder, schizophrenia) or\nhypnopompic hallucinations.\nOther Phencyclidine-Induced Disorders 251\nOther Phencyclidine-Induced\nDisorders\nOther phencyclidine-induced disorders are described in other chap-\nters of the book with disorders with which they share phenomenol-\nogy (see the substance/medication-induced mental disorders in these\nchapters): phencyclidine-induced psychotic disorder (“Schizophre-\nnia Spectrum and Other Psychotic Disorders”); phencyclidine-\ninduced bipolar disorder (“Bipolar and Related Disorders”); phency-\nclidine-induced depressive disorder (“Depressive Disorders”); and\nphencyclidine-induced anxiety disorder (“Anxiety Disorders”). For\nphencyclidine-induced intoxication delirium, see the criteria and dis-\ncussion of delirium in the chapter “Neurocognitive Disorders.” These\nphencyclidine-induced disorders are diagnosed instead of phencycli-\ndine intoxication only when the symptoms are sufficiently severe to\nwarrant independent clinical attention.\nOther Hallucinogen-Induced\nDisorders\nThe following other hallucinogen-induced disorders are described in\nother chapters of the book with disorders with which they share phe-\nnomenology (see the substance/medication-induced mental disor-\nders in these chapters): other hallucinogen-induced psychotic\ndisorder (“Schizophrenia Spectrum and Other Psychotic Disorders”);\nother hallucinogen-induced bipolar disorder (“Bipolar and Related\nDisorders”); other hallucinogen-induced depressive disorder (“De- C. the symptoms are not attributable to another medical condition\n(e.g., anatomical lesions and infections of the brain, visual epi-\nlepsies) and are not better explained by another mental disorder\n(e.g., delirium, major..."
}